» Articles » PMID: 18640028

European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the Role of Metabolic Imaging in the Neoadjuvant Treatment of Gastrointestinal Cancer

Abstract

Metabolic imaging and early response assessment by positron emission tomography (PET) are gaining importance in guiding treatment of localised and metastatic gastrointestinal tumours. During a workshop organised by the European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Group the most relevant research questions, methodological aspects and unmet clinical needs in this disease were discussed. Potential future trials were drafted. This paper reviews the lectures and discussions held during this workshop and summarises the action points for the further investigation of metabolic imaging to guide treatment in gastrointestinal tumours.

Citing Articles

Chances, risks and limitations of neoadjuvant therapy in surgical oncology.

Lordick F, Gockel I Innov Surg Sci. 2019; 1(1):3-11.

PMID: 31579713 PMC: 6753981. DOI: 10.1515/iss-2016-0004.


FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.

Schneider P, Eshmuminov D, Rordorf T, Vetter D, Veit-Haibach P, Weber A BMC Cancer. 2018; 18(1):548.

PMID: 29743108 PMC: 5944162. DOI: 10.1186/s12885-018-4477-4.


The role of PET and PET-CT scanning in assessing response to neoadjuvant therapy in esophageal carcinoma.

Schroer-Gunther M, Scheibler F, Wolff R, Westwood M, Baumert B, Lange S Dtsch Arztebl Int. 2015; 112(33-34):545-52.

PMID: 26356551 PMC: 4570959. DOI: 10.3238/arztebl.2015.0545.


The predictive value of 18F-FDG PET/CT for assessing pathological response and survival in locally advanced rectal cancer after neoadjuvant radiochemotherapy.

Leccisotti L, Gambacorta M, de Waure C, Stefanelli A, Barbaro B, Vecchio F Eur J Nucl Med Mol Imaging. 2015; 42(5):657-66.

PMID: 25687534 DOI: 10.1007/s00259-014-2820-9.


Towards personalized perioperative treatment for advanced gastric cancer.

Miao R, Wu A World J Gastroenterol. 2014; 20(33):11586-94.

PMID: 25206266 PMC: 4155352. DOI: 10.3748/wjg.v20.i33.11586.